Axogen Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Axogen has been growing earnings at an average annual rate of 4.2%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 10.7% per year.
Belangrijke informatie
4.2%
Groei van de winst
6.4%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 8.9% |
Inkomstengroei | 10.7% |
Rendement op eigen vermogen | -17.3% |
Nettomarge | -9.5% |
Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely
Sep 14Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?
Aug 20A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb
Jul 29Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost
Jun 12Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?
Apr 16Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump
Mar 28Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost
Jan 26We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt
Sep 10Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues
Aug 09AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?
Jan 13Is AxoGen (NASDAQ:AXGN) A Risky Investment?
Sep 10AxoGen: Investors Are Positioned Long Leading Into Q2 FY22 Earnings
Aug 02Axogen estimates Q2 revenue above consensus, reaffirms guidance
Jul 18Opbrengsten en kosten
Hoe Axogen geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 173 | -17 | 121 | 29 |
31 Mar 24 | 164 | -21 | 121 | 29 |
31 Dec 23 | 159 | -22 | 121 | 28 |
30 Sep 23 | 152 | -23 | 118 | 27 |
30 Jun 23 | 148 | -23 | 116 | 27 |
31 Mar 23 | 144 | -25 | 116 | 27 |
31 Dec 22 | 139 | -29 | 117 | 27 |
30 Sep 22 | 134 | -29 | 113 | 27 |
30 Jun 22 | 128 | -32 | 111 | 26 |
31 Mar 22 | 127 | -32 | 110 | 25 |
31 Dec 21 | 127 | -27 | 106 | 24 |
30 Sep 21 | 128 | -28 | 108 | 23 |
30 Jun 21 | 131 | -22 | 106 | 21 |
31 Mar 21 | 119 | -22 | 99 | 19 |
31 Dec 20 | 112 | -24 | 96 | 18 |
30 Sep 20 | 108 | -25 | 94 | 18 |
30 Jun 20 | 103 | -29 | 95 | 18 |
31 Mar 20 | 108 | -28 | 100 | 18 |
31 Dec 19 | 107 | -29 | 103 | 18 |
30 Sep 19 | 102 | -27 | 97 | 16 |
30 Jun 19 | 96 | -26 | 92 | 16 |
31 Mar 19 | 90 | -26 | 87 | 14 |
31 Dec 18 | 84 | -22 | 80 | 12 |
30 Sep 18 | 77 | -20 | 72 | 10 |
30 Jun 18 | 71 | -18 | 65 | 8 |
31 Mar 18 | 65 | -12 | 58 | 7 |
31 Dec 17 | 60 | -10 | 52 | 7 |
30 Sep 17 | 55 | -14 | 49 | 6 |
30 Jun 17 | 50 | -14 | 46 | 5 |
31 Mar 17 | 45 | -14 | 42 | 5 |
31 Dec 16 | 41 | -14 | 39 | 4 |
30 Sep 16 | 38 | -12 | 36 | 4 |
30 Jun 16 | 34 | -13 | 34 | 4 |
31 Mar 16 | 30 | -13 | 31 | 4 |
31 Dec 15 | 27 | -13 | 29 | 3 |
30 Sep 15 | 24 | -16 | 26 | 3 |
30 Jun 15 | 21 | -16 | 23 | 3 |
31 Mar 15 | 19 | -17 | 21 | 3 |
31 Dec 14 | 17 | -18 | 20 | 3 |
30 Sep 14 | 15 | -15 | 19 | 3 |
30 Jun 14 | 13 | -16 | 18 | 3 |
31 Mar 14 | 12 | -15 | 17 | 3 |
31 Dec 13 | 11 | -15 | 16 | 2 |
Kwaliteitswinsten: AXGN is currently unprofitable.
Groeiende winstmarge: AXGN is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: AXGN is unprofitable, but has reduced losses over the past 5 years at a rate of 4.2% per year.
Versnelling van de groei: Unable to compare AXGN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: AXGN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rendement op eigen vermogen
Hoge ROE: AXGN has a negative Return on Equity (-17.28%), as it is currently unprofitable.